Suchergebnisse - "SARS-Cov-2"

PubPharm (42)

1

The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19

enthalten in: Journal of pharmacy practice | 2022

von Aljadeed, R.

2

Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection

enthalten in: International immunopharmacology | 2022

von Vahabi, M. | Ghazanfari, T. | Sepehrnia, S.

3

An outlook on potential protein targets of COVID-19 as a druggable site

enthalten in: Molecular biology reports | 2022

von Noori, R. | Sardar, M.

4

Promising natural products against SARS-CoV-2 : Structure, function, and clinical trials

enthalten in: Phytotherapy research : PTR | 2022

von Zhao, Y. | Deng, S. | Bai, Y. | +4

5

An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations

enthalten in: Journal of ethnopharmacology | 2022

von Prajapati, S. | Malaiya, A. | Mishra, G. | +6

6

Antiviral Treatment in COVID-19 Outpatients : A Systematic Review of Randomized Controlled Trials

enthalten in: Acta medica Indonesiana | 2022

von Budi, D. | Oktavian, P. | Asmarawati, T. | +6

7

Integrating heterogeneous data to facilitate COVID-19 drug repurposing

enthalten in: Drug discovery today | 2022

von Prieto Santamaría, L. | Díaz Uzquiano, M. | Ugarte Carro, E. | +3

8

Diagnosis, prevention, and treatment of coronavirus disease : a review

enthalten in: Expert review of anti-infective therapy | 2022

von Sarangi, M. | Padhi, S. | Dheeman, S. | +4

9

Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase : A Comprehensive Review

enthalten in: Current pharmaceutical biotechnology | 2022

von Agrawal, N. | Goyal, A.

10

Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19

enthalten in: Current pharmaceutical design | 2022

von Rahman, M. | Ahmed, M. | Islam, M. | +9

1
2
3
4
5
Nächster »
[5]